Fast Market Research

Now Available: MabVax Therapeutics, Inc. - Product Pipeline Review - 2014

Fast Market Research recommends "MabVax Therapeutics, Inc. - Product Pipeline Review - 2014" from Global Markets Direct, now available


Boston, MA -- (SBWIRE) -- 02/26/2014 -- Global Market Direct's pharmaceuticals report, "MabVax Therapeutics, Inc. - Product Pipeline Review - 2014" provides data on the MabVax Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, MabVax Therapeutics, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from MabVax Therapeutics, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Report Scope

View Full Report Details and Table of Contents

- MabVax Therapeutics, Inc. - Brief MabVax Therapeutics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of MabVax Therapeutics, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of MabVax Therapeutics, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the MabVax Therapeutics, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get this Report

- Evaluate MabVax Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of MabVax Therapeutics, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the MabVax Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with MabVax Therapeutics, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of MabVax Therapeutics, Inc. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- MabVax Therapeutics, Inc. - Product Pipeline Review - 2013
- Isarna Therapeutics GmbH - Product Pipeline Review - 2014
- Antisense Therapeutics Limited - Product Pipeline Review - 2014
- Lightlake Therapeutics Inc. - Product Pipeline Review - 2014
- Allergy Therapeutics plc - Product Pipeline Review - 2014
- Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2014
- Bone Marrow Transplantation - Pipeline Review, H1 2014
- Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2014
- Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Review, H1 2014
- Genzyme Corporation - Product Pipeline Review - 2014